Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo). [electronic resource]
Producer: 19960910Description: 2083-8 p. digitalISSN:- 0250-7005
- Adolescent
- Adult
- Aged
- Antifungal Agents -- therapeutic use
- Bone Marrow Transplantation
- Busulfan -- pharmacokinetics
- Child
- Child, Preschool
- Drug Interactions
- Female
- Fluconazole -- therapeutic use
- Humans
- Immunosuppressive Agents -- pharmacokinetics
- Infant
- Itraconazole -- therapeutic use
- Male
- Metabolic Clearance Rate
- Middle Aged
- Transplantation, Autologous
- Transplantation, Homologous
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.